Control of intestinal inflammation by regulatory T … · Control of intestinal inflammation by...
Transcript of Control of intestinal inflammation by regulatory T … · Control of intestinal inflammation by...
Control of intestinal inflammation by regulatory T cells
Fiona PowrieSir William Dunn School of
PathologyUniversity of Oxford
Regulatory T cells prevent immune pathology in the intestine
DC DC
“non-inflammatory” “inflammatory”
X
InfectionInflammation
TE activity
IL-10, TGF-βTR activity
TE
Suppression
Foxp3TR
T
1. Mechanisms of TR mediated suppression of colitis2. Identification of the gut as a site of TR generation-role of specialised DC
Regulatory T Cells
1. Naturally occurring TR (CD4+CD25+Foxp3+)
Foxp3 necessary for development and functionMutations in Foxp3 gene cause lethal multi-organ inflammatory condition
Suppress response to self & foreign Ag:
AutoimmunityImmunity to infection Allergy Tumour immunity IBD Transplant rejection
2. Adaptive/Induced TR
IL-10, TGF-b, Foxp3
CD4+
CD25+
Foxp3+
CD4+
CD25+
Foxp3+
CD4+
Foxp3-CD4+
Foxp3-
IL-10
TGF-b
Foxp3
Thymus Periphery
Prevention of colitis involves IL-10, TGF-beta and CTLA4
TR cells prevent accumulation of activated DC
Directly suppress the innate response via IL-10 production
CD4 CD11c DAPIDAPI
TR cells prevent colitis
colitisXXCD4CD4++
CD45RBCD45RBhihi
CD4CD4++
CD45RBCD45RBlowlow
CD25CD25++
Powrie et al., JEM 1994, Read et al., JEM 2001, Maloy et al,. JEM 2003
RAG-/-
4wk2wk
(early)10wk
(cured)
CD4CD4++
CD45RBCD45RBhihiCD4CD4++
CD25CD25++CD45.2 CD45.1
TR cells cure colitis
TR cells cure established colitis. Proliferate in MLN and colon in close contact with TE and DC
Dependent on IL-10
Uhlig et al , JI, 2006; Mottet et al., JI 2003
Regulatory T cells in the intestine produce IL-10
Uhlig et al , JI, 2006
0.3 2.7 0.7 26.6
Foxp3Foxp3
SpleenSpleen ColonColon
IL-1
0
Apoptotic IEL
Luminal Ag
Constitutive Migration
IL-10
Gut Homing
IL-10
Ag exposure in the gut induces tolerance
OVA BSA1.30 0.14
CD4
Foxp
3
Oral administration of ovalbumin induces Foxp3+ T cells from naïve precursors
OVA BSA
5d
MLN, Spleen, Colon LP
DO11.10 SCID
CD103 a marker of gut DC
DC
E-cadherinalphaE (CD103)beta7
Gated on CD11c high
Annacker et al., JEM 2005, Lindbom et al., 2005
•αE integrin subunit
•Expressed by mucosal DC and T Cells
•Pairs with β7, binds to E-cadherin on epithelial cells
Functional properties of CD103+ DC
CD103+ CD103-
Naïve T cellProliferation ++ ++
IFN-gamma - +
InflammatoryCytokines (IL-6, IL-23) - +
Imprint gut homingReceptors ++ -
CD103 expression in RAG-/- required for TR activityAnnacker et al., JEM 2005; Coombes et al., JEM 2007
Sorting DC for in vitro T cell differentiation assay
Balb/c
MLNCD11c MACS
CD103+ and CD103- subsets sorted on MoFlo
CD103
CD
11c
d4+ OVAp
analysis
d7
analysis
αCD3 d8
CD103+
CD103-
CFSE Naïve D011.10/SCID
CD4+ T
cytokines
IL-2
CD103+ DC promote the expression of Foxp3 by naïve T cells
CD103+ CD103-
CFSE
Foxp
3
1x10^5 0.5x10^5 0.25x10^50123456789
CD103+CD103-
p%
Fox
p3+
DC
T
CD103?
Proliferation
CytokinesHoming
Regulatory Regulatory Properties?Properties?
CD4
Foxp
3
Induction of Foxp3 by CD103+ DC is TGF-β dependent
- 0.1ng/ml 1ng/ml0
10
20
30
40
50CD103+CD103-
[TGF-β]
% F
oxp3
+
TGF-β-mediated induction of Foxp3 is increased in the presence of CD103+DC
0
10
20
30
40
50
Rel
ativ
e ex
pres
sion
/HPR
TCD103+ CD103-
aldh1a2
CD103+ DCs express higher levels of retinal dehydrogenase than CD103- DCs
Retinol (Vitamin A)
Retinoic Acid
Retinal
Cellular Retinoid Metabolism
ADHsSDR
ALDH1A1ALDH1A2ALDH1A3
Mucosal epithelial cells and CD11c+ DCs in the dome areas of the small intestine express ALDH1A1, whilst MLN-DCs express ALDH1A2 (Iwata et al., Immunity, 2004)
+ TGF-β + TGF-β/RA
CD103+
CD103-
beta
7
Foxp3
CD103+ CD103- CD103+
+RACD103-
+RA
0
20
40
60
% F
oxp3
+
p<0.001
p<0.001
ns
Retinoic acid acts as a co-factor for Foxp3 induction
Spontaneous induction of Foxp3 in the presence of CD103+ DC is inhibited by an RAR antagonistFoxp3+ cells suppress T cell proliferation in vitro (Yasmine Belkaid, Jason Hall) Coombes et al., 2007; Hall et al., 2007; Benson et al. 2007; Murcida et al 2007
Summary
•Natural TR cells respond to inflammation and cure established colitis
•Compartmentalisation of the TR response-key role of IL-10 in control of tissue inflammation
•Gut is a site that favours induction of Foxp3+TR cells
•GALT contains functionally specialised CD103+ DC
•CD103+ DC imprint gut homing receptors on T cells and induce FoxP3 expression by a TGF-β and RA dependent mechanism
•A mechanism to broaden the repertoire of TR cells responding to intestinal antigens
•In addition to natural TR cells, induced TR may play an important role in intestinal homeostasis
MLN
DC
T
CD103
?
Foxp3
IFNγCCR9
Colon
CD103
E-cadherin
DC TGF-βRA
CD103+ DC: mucosal DC that support the development of Foxp3+ TR cells with a mucosal seeking phenotype
Gut conditioningTGF-β, Vit A
DC
Tn
N N
TregTreg
Treg Treg
Foxp3+
MN
IL-23
IL-17IFN-γ
IL-6TNF-α
Th1Th1
Th1
TR activity
Ab blockadeTGF-β
IL-10
Dysregulatedresponses
Complimentary therapies for intestinal inflammation?
SWDSP:
Chris MottetHolm UhligOliver AnnackerAna IzcueJanine CoombesSophie HueSophia BuonocoreKarima SiddiquiKevin Maloy
Wellcome TrustMRCEU
Acknowledgements
NIHYasmine BelkaidJason Hall